<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Tue, 16 Jul 2024 06:15:09 +0000</lastbuilddate>
<pubDate>Mon, 15 Jul 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Weekly Journal Scan: The prognostic value of coronary inflammation in patients with non-obstructive coronary artery disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39010255/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jul 16:ehae430. doi: 10.1093/eurheartj/ehae430. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39010255/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">39010255</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae430>10.1093/eurheartj/ehae430</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39010255</guid>
<pubDate>Mon, 15 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Rocco Vergallo</dc:creator>
<dc:creator>Giovanna Liuzzo</dc:creator>
<dc:date>2024-07-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Weekly Journal Scan: The prognostic value of coronary inflammation in patients with non-obstructive coronary artery disease</dc:title>
<dc:identifier>pmid:39010255</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae430</dc:identifier>
</item>
<item>
<title>Cardiac involvement in Chagas disease and African trypanosomiasis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39009679/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>Trypanosomiases are diseases caused by various species of protozoan parasite in the genus Trypanosoma, each presenting with distinct clinical manifestations and prognoses. Infections can affect multiple organs, with Trypanosoma cruzi predominantly affecting the heart and digestive system, leading to American trypanosomiasis or Chagas disease, and Trypanosoma brucei primarily causing a disease of the central nervous system known as human African trypanosomiasis or sleeping sickness. In this...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Jul 15. doi: 10.1038/s41569-024-01057-3. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Trypanosomiases are diseases caused by various species of protozoan parasite in the genus Trypanosoma, each presenting with distinct clinical manifestations and prognoses. Infections can affect multiple organs, with Trypanosoma cruzi predominantly affecting the heart and digestive system, leading to American trypanosomiasis or Chagas disease, and Trypanosoma brucei primarily causing a disease of the central nervous system known as human African trypanosomiasis or sleeping sickness. In this Review, we discuss the effects of these infections on the heart, with particular emphasis on Chagas disease, which continues to be a leading cause of cardiomyopathy in Latin America. The epidemiology of Chagas disease has changed substantially since 1990 owing to the emigration of over 30 million Latin American citizens, primarily to Europe and the USA. This movement of people has led to the global dissemination of individuals infected with T. cruzi. Therefore, cardiologists worldwide must familiarize themselves with Chagas disease and the severe, chronic manifestation - Chagas cardiomyopathy - because of the expanded prevalence of this disease beyond traditional endemic regions.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39009679/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">39009679</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01057-3>10.1038/s41569-024-01057-3</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39009679</guid>
<pubDate>Mon, 15 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Ester Cerdeira Sabino</dc:creator>
<dc:creator>Maria Carmo P Nunes</dc:creator>
<dc:creator>Johannes Blum</dc:creator>
<dc:creator>Israel Molina</dc:creator>
<dc:creator>Antonio Luiz P Ribeiro</dc:creator>
<dc:date>2024-07-15</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Cardiac involvement in Chagas disease and African trypanosomiasis</dc:title>
<dc:identifier>pmid:39009679</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01057-3</dc:identifier>
</item>
<item>
<title>Digital Footprints of Obesity Treatment: GLP-1 Receptor Agonists and the Health Equity Divide</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39008562/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>Our research investigates the societal implications of access to glucagon-like peptide-1 (GLP-1) agonists, particularly in light of recent clinical trials demonstrating the efficacy of semaglutide in reducing cardiovascular mortality. A decade-long analysis of Google Trends indicates a significant increase in searches for GLP-1 agonists, primarily in North America. This trend contrasts with the global prevalence of obesity. Given the high cost of GLP-1 agonists, a critical question arises: Will...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 16;150(3):171-173. doi: 10.1161/CIRCULATIONAHA.124.069680. Epub 2024 Jul 15.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Our research investigates the societal implications of access to glucagon-like peptide-1 (GLP-1) agonists, particularly in light of recent clinical trials demonstrating the efficacy of semaglutide in reducing cardiovascular mortality. A decade-long analysis of Google Trends indicates a significant increase in searches for GLP-1 agonists, primarily in North America. This trend contrasts with the global prevalence of obesity. Given the high cost of GLP-1 agonists, a critical question arises: Will this disparity in medication accessibility exacerbate the global health equity gap in obesity treatment? This viewpoint explores strategies to address the health equity gap exacerbated by this emerging medication. Because GLP-1 agonists hold the potential to become a cornerstone in obesity treatment, ensuring equitable access is a pressing public health concern.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39008562/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">39008562</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069680>10.1161/CIRCULATIONAHA.124.069680</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39008562</guid>
<pubDate>Mon, 15 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Zahra Azizi</dc:creator>
<dc:creator>Fatima Rodriguez</dc:creator>
<dc:creator>Themistocles L Assimes</dc:creator>
<dc:date>2024-07-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Digital Footprints of Obesity Treatment: GLP-1 Receptor Agonists and the Health Equity Divide</dc:title>
<dc:identifier>pmid:39008562</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069680</dc:identifier>
</item>
<item>
<title>Racial Differences in the Burden of Atherosclerotic Cardiovascular Disease Related to Elevated Lipoprotein(a) Levels: The ARIC Study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39008561/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 16;150(3):250-252. doi: 10.1161/CIRCULATIONAHA.124.069582. Epub 2024 Jul 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39008561/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">39008561</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069582>10.1161/CIRCULATIONAHA.124.069582</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39008561</guid>
<pubDate>Mon, 15 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Jelani K Grant</dc:creator>
<dc:creator>Seth S Martin</dc:creator>
<dc:creator>Sui Zhang</dc:creator>
<dc:creator>Kunihiro Matsushita</dc:creator>
<dc:creator>Salim S Virani</dc:creator>
<dc:creator>Roger S Blumenthal</dc:creator>
<dc:creator>Ron C Hoogeveen</dc:creator>
<dc:creator>Eric Boerwinkle</dc:creator>
<dc:creator>Christie M Ballantyne</dc:creator>
<dc:creator>Josef Coresh</dc:creator>
<dc:creator>Chiadi E Ndumele</dc:creator>
<dc:date>2024-07-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Racial Differences in the Burden of Atherosclerotic Cardiovascular Disease Related to Elevated Lipoprotein(a) Levels: The ARIC Study</dc:title>
<dc:identifier>pmid:39008561</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069582</dc:identifier>
</item>
<item>
<title>Working to Promote Health Equity: The Fourth Annual Disparities Issue</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39008560/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 16;150(3):169-170. doi: 10.1161/CIRCULATIONAHA.124.070825. Epub 2024 Jul 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39008560/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">39008560</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070825>10.1161/CIRCULATIONAHA.124.070825</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39008560</guid>
<pubDate>Mon, 15 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Mercedes R Carnethon</dc:creator>
<dc:creator>Latha Palaniappan</dc:creator>
<dc:creator>Karol Watson</dc:creator>
<dc:date>2024-07-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Working to Promote Health Equity: The Fourth Annual Disparities Issue</dc:title>
<dc:identifier>pmid:39008560</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070825</dc:identifier>
</item>
<item>
<title>Dietary Acculturation Is Associated With Altered Gut Microbiome, Circulating Metabolites, and Cardiovascular Disease Risk in US Hispanics and Latinos: Results From HCHS/SOL</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39008559/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Among US Hispanic and Latino adults, greater dietary acculturation was associated with elevated CVD risk, possibly through alterations in gut microbiota and related metabolites. Diet and microbiota-targeted interventions may offer opportunities to mitigate CVD burdens of dietary acculturation.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 16;150(3):215-229. doi: 10.1161/CIRCULATIONAHA.124.069824. Epub 2024 Jun 19.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Dietary acculturation, or adoption of dominant culture diet by migrant groups, influences human health. We aimed to examine dietary acculturation and its relationships with cardiovascular disease (CVD), gut microbiota, and blood metabolites among US Hispanic and Latino adults.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: In the HCHS/SOL (Hispanic Community Health Study/Study of Latinos), US exposure was defined by years in the United States (50 states and Washington, DC) and US nativity. A dietary acculturation pattern was derived from 14 172 participants with two 24-hour dietary recalls at baseline (2008-2011) using least absolute shrinkage and selection operator regression, with food groups as predictors of US exposure. We evaluated associations of dietary acculturation with incident CVD across ≈7 years of follow-up (n=211/14 172 cases/total) and gut microbiota (n=2349; visit 2, 2014 to 2017). Serum metabolites associated with both dietary acculturation-related gut microbiota (n=694) and incident CVD (n=108/5256 cases/total) were used as proxy measures to assess the association of diet-related gut microbiome with incident CVD.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: We identified an empirical US-oriented dietary acculturation score that increased with US exposure. Higher dietary acculturation score was associated with higher risk of incident CVD (hazard ratio per SD, 1.33 [95% CI, 1.13-1.57]), adjusted for sociodemographic, lifestyle, and clinical factors. Sixty-nine microbial species (17 enriched from diverse species, 52 depleted mainly from fiber-utilizing <i>Clostridia</i> and <i>Prevotella</i> species) were associated with dietary acculturation, driven by lower intakes of whole grains, beans, and fruits and higher intakes of refined grains. Twenty-five metabolites, involved predominantly in fatty acid and glycerophospholipid metabolism (eg, branched-chain 14:0 dicarboxylic acid** and glycerophosphoethanolamine), were associated with both diet acculturation-related gut microbiota and incident CVD. Proxy association analysis based on these metabolites suggested a positive relationship between diet acculturation-related microbiome and risk of CVD (<i>r</i>=0.70, <i>P</i>&lt;0.001).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Among US Hispanic and Latino adults, greater dietary acculturation was associated with elevated CVD risk, possibly through alterations in gut microbiota and related metabolites. Diet and microbiota-targeted interventions may offer opportunities to mitigate CVD burdens of dietary acculturation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39008559/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">39008559</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069824>10.1161/CIRCULATIONAHA.124.069824</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39008559</guid>
<pubDate>Mon, 15 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Yi Wang</dc:creator>
<dc:creator>Guo-Chong Chen</dc:creator>
<dc:creator>Zheng Wang</dc:creator>
<dc:creator>Kai Luo</dc:creator>
<dc:creator>Yanbo Zhang</dc:creator>
<dc:creator>Yang Li</dc:creator>
<dc:creator>Amanda C McClain</dc:creator>
<dc:creator>Marta M Jankowska</dc:creator>
<dc:creator>Krista M Perreira</dc:creator>
<dc:creator>Josiemer Mattei</dc:creator>
<dc:creator>Carmen R Isasi</dc:creator>
<dc:creator>Maria M Llabre</dc:creator>
<dc:creator>Bharat Thyagarajan</dc:creator>
<dc:creator>Martha L Daviglus</dc:creator>
<dc:creator>Linda Van Horn</dc:creator>
<dc:creator>David Goldsztajn Farelo</dc:creator>
<dc:creator>Luis E Maldonado</dc:creator>
<dc:creator>Steven R Levine</dc:creator>
<dc:creator>Bing Yu</dc:creator>
<dc:creator>Eric Boerwinkle</dc:creator>
<dc:creator>Rob Knight</dc:creator>
<dc:creator>Robert D Burk</dc:creator>
<dc:creator>Robert C Kaplan</dc:creator>
<dc:creator>Qibin Qi</dc:creator>
<dc:creator>Brandilyn A Peters</dc:creator>
<dc:date>2024-07-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Dietary Acculturation Is Associated With Altered Gut Microbiome, Circulating Metabolites, and Cardiovascular Disease Risk in US Hispanics and Latinos: Results From HCHS/SOL</dc:title>
<dc:identifier>pmid:39008559</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069824</dc:identifier>
</item>
<item>
<title>Novel Use of Z Codes to Identify Social Determinants of Cardiovascular Disease Outcomes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39008558/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 16;150(3):243-245. doi: 10.1161/CIRCULATIONAHA.124.069083. Epub 2024 Jul 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39008558/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">39008558</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069083>10.1161/CIRCULATIONAHA.124.069083</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39008558</guid>
<pubDate>Mon, 15 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Nancy Song</dc:creator>
<dc:creator>Tariku J Beyene</dc:creator>
<dc:creator>Daniel K Amponsah</dc:creator>
<dc:creator>Steven M Asch</dc:creator>
<dc:creator>Paul A Heidenreich</dc:creator>
<dc:creator>Celina M Yong</dc:creator>
<dc:date>2024-07-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Novel Use of Z Codes to Identify Social Determinants of Cardiovascular Disease Outcomes</dc:title>
<dc:identifier>pmid:39008558</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069083</dc:identifier>
</item>
<item>
<title>Childhood Opportunity and Acute Interstage Outcomes: A National Pediatric Cardiology Quality Improvement Collaborative Analysis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39008557/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Zip code COI level is associated with differences in preoperative risk factors and stage 1 palliation hospitalization characteristics. Acute interstage outcomes, although common across the spectrum of childhood opportunity, are not associated with COI level in an era of highly prevalent home monitoring programs. The role of home monitoring in mitigating disparities during the interstage period merits further investigation.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 16;150(3):190-202. doi: 10.1161/CIRCULATIONAHA.124.069127. Epub 2024 Jun 19.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: The interstage period after discharge from stage 1 palliation carries high morbidity and mortality. The impact of social determinants of health on interstage outcomes is not well characterized. We assessed the relationship between childhood opportunity and acute interstage outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Infants discharged home after stage 1 palliation in the National Pediatric Quality Improvement Collaborative Phase II registry (2016-2022) were retrospectively reviewed. Zip code-level Childhood Opportunity Index (COI), a composite metric of 29 indicators across education, health and environment, and socioeconomic domains, was used to classify patients into 5 COI levels. Acute interstage outcomes included death or transplant listing, unplanned readmission, intensive care unit admission, unplanned catheterization, and reoperation. The association between COI level and acute interstage outcomes was assessed using logistic regression with sequential adjustment for potential confounders.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The analysis cohort included 1837 patients from 69 centers. Birth weight (<i>P</i>&lt;0.001) and proximity to a surgical center at birth (<i>P</i>=0.02) increased with COI level. Stage 1 length of stay decreased (<i>P</i>=0.001), and exclusive oral feeding rate at discharge increased (<i>P</i>&lt;0.001), with higher COI level. More than 98% of patients in all COI levels were enrolled in home monitoring. Death or transplant listing occurred in 101 (5%) patients with unplanned readmission in 987 (53%), intensive care unit admission in 448 (24%), catheterization in 345 (19%), and reoperation in 83 (5%). There was no difference in the incidence or time to occurrence of any acute interstage outcome among COI levels in unadjusted or adjusted analysis. There was no interaction between race and ethnicity and childhood opportunity in acute interstage outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Zip code COI level is associated with differences in preoperative risk factors and stage 1 palliation hospitalization characteristics. Acute interstage outcomes, although common across the spectrum of childhood opportunity, are not associated with COI level in an era of highly prevalent home monitoring programs. The role of home monitoring in mitigating disparities during the interstage period merits further investigation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39008557/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">39008557</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069127>10.1161/CIRCULATIONAHA.124.069127</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39008557</guid>
<pubDate>Mon, 15 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Benjamin Zielonka</dc:creator>
<dc:creator>Emily M Bucholz</dc:creator>
<dc:creator>Minmin Lu</dc:creator>
<dc:creator>Katherine E Bates</dc:creator>
<dc:creator>Garick D Hill</dc:creator>
<dc:creator>Nelangi M Pinto</dc:creator>
<dc:creator>Lynn A Sleeper</dc:creator>
<dc:creator>David W Brown</dc:creator>
<dc:date>2024-07-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Childhood Opportunity and Acute Interstage Outcomes: A National Pediatric Cardiology Quality Improvement Collaborative Analysis</dc:title>
<dc:identifier>pmid:39008557</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069127</dc:identifier>
</item>
<item>
<title>Equitable Care for Hypertension: Blood Pressure and Patient-Reported Outcomes of the RICH LIFE Cluster Randomized Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39008556/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Adding a collaborative care team to enhanced standard of care did not improve BP control but did improve patient ratings of chronic illness care.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 16;150(3):230-242. doi: 10.1161/CIRCULATIONAHA.124.069622. Epub 2024 Jul 15.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Disparities in hypertension control are well documented but underaddressed.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: RICH LIFE (Reducing Inequities in Care of Hypertension: Lifestyle Improvement for Everyone) was a 2-arm, cluster randomized trial comparing the effect on blood pressure (BP) control (systolic BP ≤140 mm Hg, diastolic BP ≤90 mm Hg), patient activation, and disparities in BP control of 2 multilevel interventions, standard of care plus (SCP) and collaborative care/stepped care (CC/SC). SCP included BP measurement standardization, audit and feedback, and equity-leadership training. CC/SC added roles to address social or medical needs. Primary outcomes were BP control and patient activation at 12 months. Generalized estimating equations and mixed-effects regression models with fixed effects of time, intervention, and their interaction compared change in outcomes at 12 months from baseline.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 1820 adults with uncontrolled BP and ≥1 other risk factors enrolled in the study. Their mean age was 60.3 years, and baseline BP was 152.3/85.5 mm Hg; 59.4% were women; 57.4% were Black, 33.2% were White, and 9.4% were Hispanic; 74% had hyperlipidemia; and 45.1% had type 2 diabetes. CC/SC did not improve BP control rates more than SCP. Both groups achieved statistically and clinically significant BP control rates at 12 months (CC/SC: 57.3% [95% CI, 52.7%-62.0%]; SCP: 56.7% [95% CI, 51.9%-61.5%]). Pairwise comparisons between racial and ethnic groups showed overall no significant differences in BP control at 12 months. Patients with coronary heart disease showed greater achievement of BP control in CC/SC than in SCP (64.0% [95% CI, 54.1%-73.9%] versus 50.8% [95% CI, 42.6%-59.0%]; <i>P</i>=0.04), as did patients in rural areas (67.3% [95% CI, 49.8%-84.8%] versus 47.8% [95% CI, 32.4%-63.2%]; <i>P</i>=0.01). Individuals in both arms experienced statistically and clinically significant reductions in mean systolic BP (CC/SC: -13.8 mm Hg [95% CI, -15.2 to -12.5]; SCP: -14.6 mm Hg [95% CI, -15.9 to -13.2]) and diastolic BP (CC/SC: -6.9 mm Hg [95% CI, -7.8 to -6.1]; SCP: -5.5 mm Hg [95% CI, -6.4 to -4.6]) over time. The difference in diastolic BP reduction between CC/SC and SCP over time was statistically significant (-1.4 mm Hg [95% CI, -2.6 to -0.2). Patient activation did not differ between arms. CC/SC showed greater improvements in patient ratings of chronic illness care (Patient Assessment of Chronic Illness Care score) over 12 months (0.12 [95% CI, 0.02-0.22]).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Adding a collaborative care team to enhanced standard of care did not improve BP control but did improve patient ratings of chronic illness care.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39008556/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">39008556</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069622>10.1161/CIRCULATIONAHA.124.069622</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39008556</guid>
<pubDate>Mon, 15 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Lisa A Cooper</dc:creator>
<dc:creator>Jill A Marsteller</dc:creator>
<dc:creator>Kathryn A Carson</dc:creator>
<dc:creator>Katherine B Dietz</dc:creator>
<dc:creator>Romsai T Boonyasai</dc:creator>
<dc:creator>Carmen Alvarez</dc:creator>
<dc:creator>Deidra C Crews</dc:creator>
<dc:creator>Cheryl R Dennison Himmelfarb</dc:creator>
<dc:creator>Chidinma A Ibe</dc:creator>
<dc:creator>Lisa Lubomski</dc:creator>
<dc:creator>Edgar R Miller</dc:creator>
<dc:creator>Nae-Yuh Wang</dc:creator>
<dc:creator>Gideon D Avornu</dc:creator>
<dc:creator>Deven Brown</dc:creator>
<dc:creator>Debra Hickman</dc:creator>
<dc:creator>Michelle Simmons</dc:creator>
<dc:creator>Ariella Apfel Stein</dc:creator>
<dc:creator>Hsin-Chieh Yeh</dc:creator>
<dc:creator>RICH LIFE Project Investigators</dc:creator>
<dc:date>2024-07-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Equitable Care for Hypertension: Blood Pressure and Patient-Reported Outcomes of the RICH LIFE Cluster Randomized Trial</dc:title>
<dc:identifier>pmid:39008556</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069622</dc:identifier>
</item>
<item>
<title>"Asian" Heart Failure</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39008555/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 16;150(3):177-179. doi: 10.1161/CIRCULATIONAHA.123.068576. Epub 2024 Jul 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39008555/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">39008555</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.068576>10.1161/CIRCULATIONAHA.123.068576</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39008555</guid>
<pubDate>Mon, 15 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Sang Gune K Yoo</dc:creator>
<dc:creator>Carolyn S P Lam</dc:creator>
<dc:creator>Nancy K Sweitzer</dc:creator>
<dc:date>2024-07-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>"Asian" Heart Failure</dc:title>
<dc:identifier>pmid:39008555</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.068576</dc:identifier>
</item>
<item>
<title>Influence of Sex, Race and Ethnicity, and Deprivation on Survival and Completion of the Fontan Pathway for Children With Functionally Single Ventricle Heart Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39008554/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 16;150(3):246-249. doi: 10.1161/CIRCULATIONAHA.124.069779. Epub 2024 Jul 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39008554/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">39008554</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069779>10.1161/CIRCULATIONAHA.124.069779</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39008554</guid>
<pubDate>Mon, 15 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Rachel L Knowles</dc:creator>
<dc:creator>Deborah Ridout</dc:creator>
<dc:creator>Qi Huang</dc:creator>
<dc:creator>Rodney C Franklin</dc:creator>
<dc:creator>Anna N Seale</dc:creator>
<dc:creator>Hannah Bellsham-Revell</dc:creator>
<dc:creator>Ferran Espuny-Pujol</dc:creator>
<dc:creator>Katherine L Brown</dc:creator>
<dc:date>2024-07-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Influence of Sex, Race and Ethnicity, and Deprivation on Survival and Completion of the Fontan Pathway for Children With Functionally Single Ventricle Heart Disease</dc:title>
<dc:identifier>pmid:39008554</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069779</dc:identifier>
</item>
<item>
<title>Advancing Cardiovascular Health Equity With Artificial Intelligence: A Collective Ethical Responsibility</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39008553/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 16;150(3):174-176. doi: 10.1161/CIRCULATIONAHA.124.068113. Epub 2024 Jul 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39008553/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">39008553</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.068113>10.1161/CIRCULATIONAHA.124.068113</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39008553</guid>
<pubDate>Mon, 15 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Demilade Adedinsewo</dc:creator>
<dc:date>2024-07-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Advancing Cardiovascular Health Equity With Artificial Intelligence: A Collective Ethical Responsibility</dc:title>
<dc:identifier>pmid:39008553</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.068113</dc:identifier>
</item>
<item>
<title>Novel Long Noncoding RNA &lt;em>;HEAT4&lt;/em>; Affects Monocyte Subtypes, Reducing Inflammation and Promoting Vascular Healing</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39005211/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: These results characterize a novel endogenous anti-inflammatory pathway that involves the conversion of monocyte subtypes into anti-inflammatory CD16^(+) monocytes. The data identify a novel function for the class of long noncoding RNAs by preventing protein secretion and suggest long noncoding RNAs as potential targets for interventions in the field of cardioimmunology.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 15. doi: 10.1161/CIRCULATIONAHA.124.069315. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Activation of the immune system contributes to cardiovascular diseases. The role of human-specific long noncoding RNAs in cardioimmunology is poorly understood.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Single-cell sequencing in peripheral blood mononuclear cells revealed a novel human-specific long noncoding RNA called <i>HEAT4</i> (heart failure-associated transcript 4). <i>HEAT4</i> expression was assessed in several in vitro and ex vivo models of immune cell activation, as well as in the blood of patients with heart failure (HF), acute myocardial infarction, or cardiogenic shock. The transcriptional regulation of <i>HEAT4</i> was verified through cytokine treatment and single-cell sequencing. Loss-of-function and gain-of-function studies and multiple RNA-protein interaction assays uncovered a mechanistic role of <i>HEAT4</i> in the monocyte anti-inflammatory gene program. <i>HEAT4</i> expression and function was characterized in a vascular injury model in NOD.CB17-Prkdc scid/Rj mice.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: <i>HEAT4</i> expression was increased in the blood of patients with HF, acute myocardial infarction, or cardiogenic shock. <i>HEAT4</i> levels distinguished patients with HF from people without HF and predicted all-cause mortality in a cohort of patients with HF over 7 years of follow-up. Monocytes, particularly anti-inflammatory CD16<sup>+</sup> monocytes, which are increased in patients with HF, are the primary source of <i>HEAT4</i> expression in the blood. <i>HEAT4</i> is transcriptionally activated by treatment with anti-inflammatory interleukin-10. <i>HEAT4</i> activates anti-inflammatory and inhibits proinflammatory gene expression. Increased <i>HEAT4</i> levels result in a shift toward more CD16<sup>+</sup> monocytes. <i>HEAT4</i> binds to S100A9, causing a monocyte subtype switch, thereby reducing inflammation. As a result, <i>HEAT4</i> improves endothelial barrier integrity during inflammation and promotes vascular healing after injury in mice.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: These results characterize a novel endogenous anti-inflammatory pathway that involves the conversion of monocyte subtypes into anti-inflammatory CD16<sup>+</sup> monocytes. The data identify a novel function for the class of long noncoding RNAs by preventing protein secretion and suggest long noncoding RNAs as potential targets for interventions in the field of cardioimmunology.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39005211/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">39005211</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069315>10.1161/CIRCULATIONAHA.124.069315</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39005211</guid>
<pubDate>Mon, 15 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Jasmin M Kneuer</dc:creator>
<dc:creator>Ignacy A Grajek</dc:creator>
<dc:creator>Melanie Winkler</dc:creator>
<dc:creator>Stephan Erbe</dc:creator>
<dc:creator>Tim Meinecke</dc:creator>
<dc:creator>Ronald Weiss</dc:creator>
<dc:creator>Tania Garfias-Veitl</dc:creator>
<dc:creator>Bilal N Sheikh</dc:creator>
<dc:creator>Ann-Christine König</dc:creator>
<dc:creator>Maximilian N Möbius-Winkler</dc:creator>
<dc:creator>Alexander Kogel</dc:creator>
<dc:creator>Karl-Patrik Kresoja</dc:creator>
<dc:creator>Sebastian Rosch</dc:creator>
<dc:creator>Karoline E Kokot</dc:creator>
<dc:creator>Vanina Filipova</dc:creator>
<dc:creator>Susanne Gaul</dc:creator>
<dc:creator>Holger Thiele</dc:creator>
<dc:creator>Philipp Lurz</dc:creator>
<dc:creator>Stephan von Haehling</dc:creator>
<dc:creator>Thimoteus Speer</dc:creator>
<dc:creator>Ulrich Laufs</dc:creator>
<dc:creator>Jes-Niels Boeckel</dc:creator>
<dc:date>2024-07-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Novel Long Noncoding RNA &lt;em>;HEAT4&lt;/em>; Affects Monocyte Subtypes, Reducing Inflammation and Promoting Vascular Healing</dc:title>
<dc:identifier>pmid:39005211</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069315</dc:identifier>
</item>
<item>
<title>Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39005209/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: LOY identifies male patients with chronic kidney disease at high risk for mortality and heart failure events.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 15. doi: 10.1161/CIRCULATIONAHA.124.069139. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Chronic kidney disease represents one of the strongest risk factors for cardiovascular diseases, and particularly for heart failure. Despite improved pharmaceutical treatments, mortality remains high. Recently, experimental studies demonstrated that mosaic loss of Y chromosome (LOY) associates with cardiac fibrosis in male mice. Since diffuse cardiac fibrosis is the common denominator for progression of all forms of heart failure, we determined the association of LOY on mortality and cardiovascular disease outcomes in patients with chronic kidney disease.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: LOY was quantified in men with stable chronic kidney disease (CARE for HOMe study [XXX], n=279) and dialysis patients (4D study, n=544). The association between LOY and mortality, combined cardiovascular and heart failure-specific end points, and echocardiographic measures was assessed.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: In CARE for HOMe, the frequency of LOY increased with age. LOY >;17% was associated with increased mortality (heart rate, 2.58 [95% CI, 1.33-5.03]) and risk for cardiac decompensation or death (heart rate, 2.30 [95% CI, 1.23-4.27]). Patients with LOY >;17% showed a significant decline of ejection fraction and an increase of E/E' within 5 years. Consistently, in the 4D study, LOY >;17% was significantly associated with increased mortality (heart rate, 2.76 [95% CI, 1.83-4.16]), higher risk of death due to heart failure and sudden cardiac death (heart rate, 4.11 [95% CI, 2.09-8.08]), but not atherosclerotic events. Patients with LOY >;17% showed significantly higher plasma levels of soluble interleukin 1 receptor-like 1, a biomarker for myocardial fibrosis. Mechanistically, intermediate monocytes from patients with LOY >;17% showed significantly higher C-C chemokine receptor type 2 expression and higher plasma levels of the C-C chemokine receptor type 2 chemokine (C-C motif) ligand 2, which may have contributed to increased heart failure events.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: LOY identifies male patients with chronic kidney disease at high risk for mortality and heart failure events.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39005209/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">39005209</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069139>10.1161/CIRCULATIONAHA.124.069139</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39005209</guid>
<pubDate>Mon, 15 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Michael Weyrich</dc:creator>
<dc:creator>Sebastian Cremer</dc:creator>
<dc:creator>Martin Gerster</dc:creator>
<dc:creator>Tamim Sarakpi</dc:creator>
<dc:creator>Tina Rasper</dc:creator>
<dc:creator>Stephen Zewinger</dc:creator>
<dc:creator>Sammy R Patyna</dc:creator>
<dc:creator>David M Leistner</dc:creator>
<dc:creator>Gunnar H Heine</dc:creator>
<dc:creator>Christoph Wanner</dc:creator>
<dc:creator>Winfried März</dc:creator>
<dc:creator>Danilo Fliser</dc:creator>
<dc:creator>Stefanie Dimmeler</dc:creator>
<dc:creator>Andreas M Zeiher</dc:creator>
<dc:creator>Thimoteus Speer</dc:creator>
<dc:date>2024-07-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease</dc:title>
<dc:identifier>pmid:39005209</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069139</dc:identifier>
</item>
<item>
<title>Molecular and cellular mechanisms of teneurin signaling in synaptic partner matching</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38996528/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>In developing brains, axons exhibit remarkable precision in selecting synaptic partners among many non-partner cells. Evolutionarily conserved teneurins are transmembrane proteins that instruct synaptic partner matching. However, how intracellular signaling pathways execute teneurins' functions is unclear. Here, we use in situ proximity labeling to obtain the intracellular interactome of a teneurin (Ten-m) in the Drosophila brain. Genetic interaction studies using quantitative partner matching...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 3:S0092-8674(24)00696-2. doi: 10.1016/j.cell.2024.06.022. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">In developing brains, axons exhibit remarkable precision in selecting synaptic partners among many non-partner cells. Evolutionarily conserved teneurins are transmembrane proteins that instruct synaptic partner matching. However, how intracellular signaling pathways execute teneurins' functions is unclear. Here, we use in situ proximity labeling to obtain the intracellular interactome of a teneurin (Ten-m) in the Drosophila brain. Genetic interaction studies using quantitative partner matching assays in both olfactory receptor neurons (ORNs) and projection neurons (PNs) reveal a common pathway: Ten-m binds to and negatively regulates a RhoGAP, thus activating the Rac1 small GTPases to promote synaptic partner matching. Developmental analyses with single-axon resolution identify the cellular mechanism of synaptic partner matching: Ten-m signaling promotes local F-actin levels and stabilizes ORN axon branches that contact partner PN dendrites. Combining spatial proteomics and high-resolution phenotypic analyses, this study advanced our understanding of both cellular and molecular mechanisms of synaptic partner matching.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38996528/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">38996528</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.022>10.1016/j.cell.2024.06.022</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38996528</guid>
<pubDate>Fri, 12 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Chuanyun Xu</dc:creator>
<dc:creator>Zhuoran Li</dc:creator>
<dc:creator>Cheng Lyu</dc:creator>
<dc:creator>Yixin Hu</dc:creator>
<dc:creator>Colleen N McLaughlin</dc:creator>
<dc:creator>Kenneth Kin Lam Wong</dc:creator>
<dc:creator>Qijing Xie</dc:creator>
<dc:creator>David J Luginbuhl</dc:creator>
<dc:creator>Hongjie Li</dc:creator>
<dc:creator>Namrata D Udeshi</dc:creator>
<dc:creator>Tanya Svinkina</dc:creator>
<dc:creator>D R Mani</dc:creator>
<dc:creator>Shuo Han</dc:creator>
<dc:creator>Tongchao Li</dc:creator>
<dc:creator>Yang Li</dc:creator>
<dc:creator>Ricardo Guajardo</dc:creator>
<dc:creator>Alice Y Ting</dc:creator>
<dc:creator>Steven A Carr</dc:creator>
<dc:creator>Jiefu Li</dc:creator>
<dc:creator>Liqun Luo</dc:creator>
<dc:date>2024-07-12</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Molecular and cellular mechanisms of teneurin signaling in synaptic partner matching</dc:title>
<dc:identifier>pmid:38996528</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.022</dc:identifier>
</item>
<item>
<title>Assembly and activation of EBV latent membrane protein 1</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38996527/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>Latent membrane protein 1 (LMP1) is the primary oncoprotein of Epstein-Barr virus (EBV) and plays versatile roles in the EBV life cycle and pathogenesis. Despite decades of extensive research, the molecular basis for LMP1 folding, assembly, and activation remains unclear. Here, we report cryo-electron microscopy structures of LMP1 in two unexpected assemblies: a symmetric homodimer and a higher-order filamentous oligomer. LMP1 adopts a non-canonical and unpredicted fold that supports the...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 4:S0092-8674(24)00695-0. doi: 10.1016/j.cell.2024.06.021. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Latent membrane protein 1 (LMP1) is the primary oncoprotein of Epstein-Barr virus (EBV) and plays versatile roles in the EBV life cycle and pathogenesis. Despite decades of extensive research, the molecular basis for LMP1 folding, assembly, and activation remains unclear. Here, we report cryo-electron microscopy structures of LMP1 in two unexpected assemblies: a symmetric homodimer and a higher-order filamentous oligomer. LMP1 adopts a non-canonical and unpredicted fold that supports the formation of a stable homodimer through tight and antiparallel intermolecular packing. LMP1 dimers further assemble side-by-side into higher-order filamentous oligomers, thereby allowing the accumulation and specific organization of the flexible cytoplasmic tails for efficient recruitment of downstream factors. Super-resolution microscopy and cellular functional assays demonstrate that mutations at both dimeric and oligomeric interfaces disrupt LMP1 higher-order assembly and block multiple LMP1-mediated signaling pathways. Our research provides a framework for understanding the mechanism of LMP1 and for developing potential therapies targeting EBV-associated diseases.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38996527/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">38996527</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.021>10.1016/j.cell.2024.06.021</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38996527</guid>
<pubDate>Fri, 12 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Jiafeng Huang</dc:creator>
<dc:creator>Xiaolin Zhang</dc:creator>
<dc:creator>Xiaohua Nie</dc:creator>
<dc:creator>Xuyuan Zhang</dc:creator>
<dc:creator>Yong Wang</dc:creator>
<dc:creator>Linlong Huang</dc:creator>
<dc:creator>Xiaohan Geng</dc:creator>
<dc:creator>Dong Li</dc:creator>
<dc:creator>Liguo Zhang</dc:creator>
<dc:creator>Guangxia Gao</dc:creator>
<dc:creator>Pu Gao</dc:creator>
<dc:date>2024-07-12</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Assembly and activation of EBV latent membrane protein 1</dc:title>
<dc:identifier>pmid:38996527</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.021</dc:identifier>
</item>
<item>
<title>Three-dimensional genome architecture persists in a 52,000-year-old woolly mammoth skin sample</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38996487/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>Analyses of ancient DNA typically involve sequencing the surviving short oligonucleotides and aligning to genome assemblies from related, modern species. Here, we report that skin from a female woolly mammoth (†Mammuthus primigenius) that died 52,000 years ago retained its ancient genome architecture. We use PaleoHi-C to map chromatin contacts and assemble its genome, yielding 28 chromosome-length scaffolds. Chromosome territories, compartments, loops, Barr bodies, and inactive X chromosome (Xi)...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 11;187(14):3541-3562.e51. doi: 10.1016/j.cell.2024.06.002.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Analyses of ancient DNA typically involve sequencing the surviving short oligonucleotides and aligning to genome assemblies from related, modern species. Here, we report that skin from a female woolly mammoth (†Mammuthus primigenius) that died 52,000 years ago retained its ancient genome architecture. We use PaleoHi-C to map chromatin contacts and assemble its genome, yielding 28 chromosome-length scaffolds. Chromosome territories, compartments, loops, Barr bodies, and inactive X chromosome (Xi) superdomains persist. The active and inactive genome compartments in mammoth skin more closely resemble Asian elephant skin than other elephant tissues. Our analyses uncover new biology. Differences in compartmentalization reveal genes whose transcription was potentially altered in mammoths vs. elephants. Mammoth Xi has a tetradic architecture, not bipartite like human and mouse. We hypothesize that, shortly after this mammoth's death, the sample spontaneously freeze-dried in the Siberian cold, leading to a glass transition that preserved subfossils of ancient chromosomes at nanometer scale.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38996487/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">38996487</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.002>10.1016/j.cell.2024.06.002</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38996487</guid>
<pubDate>Fri, 12 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Marcela Sandoval-Velasco</dc:creator>
<dc:creator>Olga Dudchenko</dc:creator>
<dc:creator>Juan Antonio Rodríguez</dc:creator>
<dc:creator>Cynthia Pérez Estrada</dc:creator>
<dc:creator>Marianne Dehasque</dc:creator>
<dc:creator>Claudia Fontsere</dc:creator>
<dc:creator>Sarah S T Mak</dc:creator>
<dc:creator>Ruqayya Khan</dc:creator>
<dc:creator>Vinícius G Contessoto</dc:creator>
<dc:creator>Antonio B Oliveira Junior</dc:creator>
<dc:creator>Achyuth Kalluchi</dc:creator>
<dc:creator>Bernardo J Zubillaga Herrera</dc:creator>
<dc:creator>Jiyun Jeong</dc:creator>
<dc:creator>Renata P Roy</dc:creator>
<dc:creator>Ishawnia Christopher</dc:creator>
<dc:creator>David Weisz</dc:creator>
<dc:creator>Arina D Omer</dc:creator>
<dc:creator>Sanjit S Batra</dc:creator>
<dc:creator>Muhammad S Shamim</dc:creator>
<dc:creator>Neva C Durand</dc:creator>
<dc:creator>Brendan O'Connell</dc:creator>
<dc:creator>Alfred L Roca</dc:creator>
<dc:creator>Maksim V Plikus</dc:creator>
<dc:creator>Mariya A Kusliy</dc:creator>
<dc:creator>Svetlana A Romanenko</dc:creator>
<dc:creator>Natalya A Lemskaya</dc:creator>
<dc:creator>Natalya A Serdyukova</dc:creator>
<dc:creator>Svetlana A Modina</dc:creator>
<dc:creator>Polina L Perelman</dc:creator>
<dc:creator>Elena A Kizilova</dc:creator>
<dc:creator>Sergei I Baiborodin</dc:creator>
<dc:creator>Nikolai B Rubtsov</dc:creator>
<dc:creator>Gur Machol</dc:creator>
<dc:creator>Krisha Rath</dc:creator>
<dc:creator>Ragini Mahajan</dc:creator>
<dc:creator>Parwinder Kaur</dc:creator>
<dc:creator>Andreas Gnirke</dc:creator>
<dc:creator>Isabel Garcia-Treviño</dc:creator>
<dc:creator>Rob Coke</dc:creator>
<dc:creator>Joseph P Flanagan</dc:creator>
<dc:creator>Kelcie Pletch</dc:creator>
<dc:creator>Aurora Ruiz-Herrera</dc:creator>
<dc:creator>Valerii Plotnikov</dc:creator>
<dc:creator>Innokentiy S Pavlov</dc:creator>
<dc:creator>Naryya I Pavlova</dc:creator>
<dc:creator>Albert V Protopopov</dc:creator>
<dc:creator>Michele Di Pierro</dc:creator>
<dc:creator>Alexander S Graphodatsky</dc:creator>
<dc:creator>Eric S Lander</dc:creator>
<dc:creator>M Jordan Rowley</dc:creator>
<dc:creator>Peter G Wolynes</dc:creator>
<dc:creator>José N Onuchic</dc:creator>
<dc:creator>Love Dalén</dc:creator>
<dc:creator>Marc A Marti-Renom</dc:creator>
<dc:creator>M Thomas P Gilbert</dc:creator>
<dc:creator>Erez Lieberman Aiden</dc:creator>
<dc:date>2024-07-12</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Three-dimensional genome architecture persists in a 52,000-year-old woolly mammoth skin sample</dc:title>
<dc:identifier>pmid:38996487</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.002</dc:identifier>
</item>
<item>
<title>Immune mechanisms in fibrotic interstitial lung disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38996486/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>Fibrotic interstitial lung diseases (fILDs) have poor survival rates and lack effective therapies. Despite evidence for immune mechanisms in lung fibrosis, immunotherapies have been unsuccessful for major types of fILD. Here, we review immunological mechanisms in lung fibrosis that have the potential to impact clinical practice. We first examine innate immunity, which is broadly involved across fILD subtypes. We illustrate how innate immunity in fILD involves a complex interplay of multiple cell...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 11;187(14):3506-3530. doi: 10.1016/j.cell.2024.05.015.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Fibrotic interstitial lung diseases (fILDs) have poor survival rates and lack effective therapies. Despite evidence for immune mechanisms in lung fibrosis, immunotherapies have been unsuccessful for major types of fILD. Here, we review immunological mechanisms in lung fibrosis that have the potential to impact clinical practice. We first examine innate immunity, which is broadly involved across fILD subtypes. We illustrate how innate immunity in fILD involves a complex interplay of multiple cell subpopulations and molecular pathways. We then review the growing evidence for adaptive immunity in lung fibrosis to provoke a re-examination of its role in clinical fILD. We close with future directions to address key knowledge gaps in fILD pathobiology: (1) longitudinal studies emphasizing early-stage clinical disease, (2) immune mechanisms of acute exacerbations, and (3) next-generation immunophenotyping integrating spatial, genetic, and single-cell approaches. Advances in these areas are essential for the future of precision medicine and immunotherapy in fILD.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38996486/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">38996486</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11246539/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">PMC11246539</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.05.015>10.1016/j.cell.2024.05.015</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38996486</guid>
<pubDate>Fri, 12 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Mari Kamiya</dc:creator>
<dc:creator>Hannah Carter</dc:creator>
<dc:creator>Milena S Espindola</dc:creator>
<dc:creator>Tracy J Doyle</dc:creator>
<dc:creator>Joyce S Lee</dc:creator>
<dc:creator>Louis T Merriam</dc:creator>
<dc:creator>Fan Zhang</dc:creator>
<dc:creator>Leticia Kawano-Dourado</dc:creator>
<dc:creator>Jeffrey A Sparks</dc:creator>
<dc:creator>Cory M Hogaboam</dc:creator>
<dc:creator>Bethany B Moore</dc:creator>
<dc:creator>William M Oldham</dc:creator>
<dc:creator>Edy Y Kim</dc:creator>
<dc:date>2024-07-12</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Immune mechanisms in fibrotic interstitial lung disease</dc:title>
<dc:identifier>pmid:38996486</dc:identifier>
<dc:identifier>pmc:PMC11246539</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.05.015</dc:identifier>
</item>
<item>
<title>Timing is everything: How plants optimize reproduction in a variable environment</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38996485/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>Organisms experience a constantly changing environment and must adjust their development to maximize fitness. These "life histories" are fantastically diverse and have fascinated biologists for decades. Recent work published in Cell reveals the complex genetic mechanisms that drive life-history variation within and among species in the Brassicaceae plant family.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 11;187(14):3504-3505. doi: 10.1016/j.cell.2024.05.054.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Organisms experience a constantly changing environment and must adjust their development to maximize fitness. These "life histories" are fantastically diverse and have fascinated biologists for decades. Recent work published in Cell reveals the complex genetic mechanisms that drive life-history variation within and among species in the Brassicaceae plant family.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38996485/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">38996485</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.05.054>10.1016/j.cell.2024.05.054</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38996485</guid>
<pubDate>Fri, 12 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>David L Des Marais</dc:creator>
<dc:date>2024-07-12</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Timing is everything: How plants optimize reproduction in a variable environment</dc:title>
<dc:identifier>pmid:38996485</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.05.054</dc:identifier>
</item>
<item>
<title>Reduction hits the sweet spot: A revised biosynthesis of dolichol</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38996484/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>Dolichol is a lipid that is involved in protein glycosylation, a process that is essential for all eukaryotic life. In this issue of Cell, Wilson and coworkers¹ report how a rare human genetic disorder led to the discovery of dolichol biosynthesis.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 11;187(14):3502-3503. doi: 10.1016/j.cell.2024.05.006.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Dolichol is a lipid that is involved in protein glycosylation, a process that is essential for all eukaryotic life. In this issue of Cell, Wilson and coworkers<sup>1</sup> report how a rare human genetic disorder led to the discovery of dolichol biosynthesis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38996484/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">38996484</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.05.006>10.1016/j.cell.2024.05.006</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38996484</guid>
<pubDate>Fri, 12 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Sarah E O'Connor</dc:creator>
<dc:date>2024-07-12</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Reduction hits the sweet spot: A revised biosynthesis of dolichol</dc:title>
<dc:identifier>pmid:38996484</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.05.006</dc:identifier>
</item>
<item>
<title>Advancing accessible science for low-vision and diverse-needs communities</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38996483/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240716021507&amp;v=2.18.0.post9+e462414
      <description>Science can often be inaccessible for people with disabilities, including those with low vision or blindness. Below, we hear from Jamie Rossjohn and Erica Tandori regarding the insights and experiences into the establishment of an internship program for people with disabilities and the evolution of Monash Sensory Science-from a one-off exhibition event for blind and low-vision communities to a national and international multisensory, accessible science initiative, championing a more inclusive...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 11;187(14):3496-3501. doi: 10.1016/j.cell.2024.05.020.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Science can often be inaccessible for people with disabilities, including those with low vision or blindness. Below, we hear from Jamie Rossjohn and Erica Tandori regarding the insights and experiences into the establishment of an internship program for people with disabilities and the evolution of Monash Sensory Science-from a one-off exhibition event for blind and low-vision communities to a national and international multisensory, accessible science initiative, championing a more inclusive approach to science communication.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38996483/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240716021507&v=2.18.0.post9+e462414">38996483</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.05.020>10.1016/j.cell.2024.05.020</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38996483</guid>
<pubDate>Fri, 12 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Erica Tandori</dc:creator>
<dc:creator>Jamie Rossjohn</dc:creator>
<dc:date>2024-07-12</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Advancing accessible science for low-vision and diverse-needs communities</dc:title>
<dc:identifier>pmid:38996483</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.05.020</dc:identifier>
</item>





























</channel>
</rss>